Overview Fundamentals API Earnings EOD API Sample Code Pricing

Eyepoint Pharmaceuticals Inc (EYPT NASDAQ) stock market data APIs

$8.92 -0.65(-6.8%) as of July 23, 2024
Price chart is built with Anychart

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Eyepoint Pharmaceuticals Inc Financial Data Overview

498 M
52 084 K
50 019 K
Our easy-to-use no-coding solutions help you get the data effortlessly:

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'EYPT',
Type: 'Common Stock',
Name: 'Eyepoint Pharmaceuticals Inc',
Exchange: 'NASDAQ',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000F90JX5',
CIK: '1314102',
EmployerIdNumber: '26-2774444',
FiscalYearEnd: 'December',
IPODate: '2005-01-27',
InternationalDomestic: 'International/Domestic',
Sector: 'Healthcare',
Industry: 'Biotechnology',
HomeCategory: 'Domestic',
IsDelisted: false,

Eyepoint Pharmaceuticals Inc Fundamental Data is available in our Financial Data APIs

  • Net Revenue 50 019 K
  • EBITDA -84 971 800
  • Earnings Per Share -1.81
  • Income Statements
  • Balance Sheets
  • Cash flows
Get sample
of Fundamental API Data

Get Eyepoint Pharmaceuticals Inc Earnings via APIs

  • Latest Release 2024-05-08
  • EPS/Forecast -0.42

Get Eyepoint Pharmaceuticals Inc End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends
Do you have any questions?